Volume 17, Number 10—October 2011
Dispatch
Seroconversion to Pandemic (H1N1) 2009 Virus and Cross-Reactive Immunity to Other Swine Influenza Viruses
Figure
![Figure. Neutralizing antibody titers to subtype H1 swine influenza viruses of the classical swine, North American triple reassortant, and Eurasian avian-like swine lineages in baseline (prepandemic [pre]) and convalescent-phase (postpandemic [post]) serum samples from 28 persons who seroconverted to pandemic (H1N1) 2009 infection, Hong Kong. Complete details on the serologic study cohort from which this subset is drawn are from (4). The pandemic A/California/4/2009 (H1N1) and seasonal influenza A/HK/400599/2008 (H1N1) viruses were used as controls. Orange lines indicate geometric mean titer; green error bars indicate 95% confidence intervals. *p<0.05; †p<0.01. Neutralizing antibody titers to subtype H1 swine influenza viruses of the classical swine, North American triple reassortant, and Eurasian avian-like swine lineages in baseline (prepandemic [pre]) and convalescent-phase (postpandemic [post]) serum samples from 28 persons who seroconverted to pandemic (H1N1) 2009 infection, Hong Kong. Complete details on the serologic study cohort from which this subset is drawn are from (4). The pandemic A/California/4/2009 (H1N1) and seasonal influenza A/HK/400](/eid/images/11-0629-F1.jpg)
Figure. Neutralizing antibody titers to subtype H1 swine influenza viruses of the classical swine, North American triple reassortant, and Eurasian avian-like swine lineages in baseline (prepandemic [pre]) and convalescent-phase (postpandemic [post]) serum samples from 28 persons who seroconverted to pandemic (H1N1) 2009 infection, Hong Kong. Complete details on the serologic study cohort from which this subset is drawn are from (4). The pandemic A/California/4/2009 (H1N1) and seasonal influenza A/HK/400599/2008 (H1N1) viruses were used as controls. Orange lines indicate geometric mean titer; green error bars indicate 95% confidence intervals. *p<0.05; †p<0.01.
References
- Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945–52. DOIPubMedGoogle Scholar
- Brockwell-Staats C, Webster RG, Webby RJ. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respi Viruses. 2009;3:207–13. DOIPubMedGoogle Scholar
- Vijaykrishna D, Smith GDJ, Pybus OG, Zhu H, Bhatt S, Poon LLM, Long-term evolution and transmission dynamics of swine influenza A virus. Nature. 2011;473:519–22. DOIPubMedGoogle Scholar
- Hung IF, To KK, Lee CK, Lin CK, Chan JF, Tse H, Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis. 2010;51:274–9. DOIPubMedGoogle Scholar